Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#21 of 1,324)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)